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Leptin acts on hypothalamic pro-opiomelanocortin
(POMC) neurons to regulate glucose homeostasis,
but the precise mechanisms remain unclear. Here,
we demonstrate that leptin-induced depolarization
of POMC neurons is associated with the augmenta-
tion of a voltage-gated calcium (CaV) conductance
with the properties of the ‘‘R-type’’ channel. Knock-
down of the pore-forming subunit of the R-type
(CaV2.3 or Cacna1e) conductance in hypothalamic
POMC neurons prevented sustained leptin-induced
depolarization. In vivo POMC-specific Cacna1e
knockdown increased hepatic glucose production
and insulin resistance, while body weight, feeding,
or leptin-induced suppression of food intake were
not changed. These findings link Cacna1e function
to leptin-mediated POMC neuron excitability and
glucose homeostasis and may provide a target for
the treatment of diabetes.INTRODUCTION
The CNS regulates glucose homeostasis by modulation of pe-
ripheral insulin sensitivity and hepatic glucose production
(HGP) (Ruud et al., 2017; Schwartz et al., 2013). Insulin and leptin
play a key role acting on hypothalamic arcuate nucleus agouti-
related peptide (AgRP) and pro-opiomelanocortin (POMC)-ex-
pressing neurons to regulate glucose homeostasis (Ruud et al.,
2017; Schwartz et al., 2013). Insulin signaling in AgRP neurons
chronically modulates glucose metabolism by altering HGP
(Ko¨nner et al., 2007). Leptin signaling in POMC neurons chroni-
cally regulates insulin sensitivity and HGP (Berglund et al.,
2012). Leptin administered to the mediobasal hypothalamus
(MBH) has an anti-diabetic effect (Morton and Schwartz, 2011)
and re-expression of leptin receptors (LepRs) into POMC neu-
rons of LepR-deficient mice restores impaired glucose homeo-
stasis (Berglund et al., 2012). However, the precise mechanisms278 Cell Reports 25, 278–287, October 9, 2018 ª 2018 The Author(s)
This is an open access article under the CC BY license (http://creativeby which leptin signaling regulates POMC neuron activity and
thereby controls glucose metabolism are not fully understood.
Leptin increases POMC neuron excitability in a phosphatidyli-
nositol-3 kinase (PI3K)-dependent manner, and prenatal loss of
POMC PI3K signaling impairs insulin sensitivity and increases
HGP (Al-Qassab et al., 2009; Hill et al., 2008; Shi et al., 2013).
Activation of a non-selective cation conductance is thought to
underlie POMC excitation (Cowley et al., 2001; Hill et al., 2008).
Qiu et al. (2010) showed that leptin excited POMC neurons by
activation of a channel composed of transient receptor poten-
tial-C (Trpc) 1, 4, 5, and 7 subunits, an action potentiated by
raised intracellular calcium. Furthermore, Trpc5 knockout in
mouse POMC neurons reduced resting excitability, abolished
leptin excitation and feeding suppression, increased body
weight, and lowered energy expenditure with no effect on
glucose homeostasis (Gao et al., 2017).
Here, we show that leptin modulates a CaV2.3 (Cacna1e) sub-
unit containing voltage-dependent calcium channel (CaV), which
is required for chronic leptin-induced excitation of POMC neu-
rons. Knockdown of Cacna1e in arcuate POMC neurons impairs
regulation of HGP in adult mice.
RESULTS
Identification of a CaV Conductance Modulated by
Leptin in POMC Neurons
As shown previously (Al-Qassab et al., 2009; Choudhury et al.,
2005; Claret et al., 2007; Cowley et al., 2001; Hill et al., 2008;
Qiu et al., 2010; Smith et al., 2015; Williams et al., 2010), local
application of leptin (50 nM; 2 min) caused long-lasting (>1-hr)
depolarization (n = 33; paired t test, t(32) = 3.63; p < 0.001; Fig-
ure 1A) in a sub-population of POMC neurons consistent with
recent RNA-sequencing (RNA-seq) data showing that only
50% of POMC neurons contain the LepR (Lam et al., 2017).
Cells that did depolarize to leptin (DVm, +4.4 ± 1.0 mV; n = 15
responsive cells out of 33) had an increased firing frequency
(2.9 ± 0.8 to 4.2 ± 0.9 Hz; n = 15 responsive cells out of 33)
and reduced input resistance (87.2 ± 7.7% of control; n = 15
responsive cells out of 33). In voltage-clamp recordings, leptin
increased the holding current by 11.4 ± 4.2 pA (n = 8; paired.
commons.org/licenses/by/4.0/).
Figure 1. Leptin Augments a Voltage-Gated Calcium Conductance
(A) Representative continuous whole-cell current-clamp trace (upper) and expanded sections (lower, as indicated by italic letters) from a POMC neuron recorded
in intact slices. Locally applied leptin (50 nM; 2 min where indicated) depolarized and increased firing frequency of a sub-population of POMC neurons.
(legend continued on next page)
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t test, t(7) = 2.70; p < 0.05) at70mV. In hyperpolarizing voltage-
ramps (10 to 100 mV) without ion channel pharmacology,
leptin evoked an outwardly rectifying current that reversed at
32.2 ± 3.6 mV (n = 8; Figure 1B). While these properties are
consistent with the activation of a Trpc5 subunit-containing
conductance, an additional leptin-dependent inward current
was evoked at potentials greater than40mV (Figure 1B). Given
the dependence of the Trpc5 conductance on intracellular cal-
cium, we therefore hypothesized that leptin may also activate a
voltage-gated calcium (CaV) conductance.
To investigate the identity and properties of POMC CaV cur-
rents, whole-cell recordings were performed with a CsCl
(130 mM) internal solution and extracellular divalent cations re-
placed with 10 mM BaCl2, to block K
+ channels and enhance
CaV currents. Recordings were also performed with tetrodotoxin
and inhibitors of fast synaptic transmission. POMCneuronswere
voltage clamped at –70 mV and Ba2+ currents evoked by 50-ms
voltage steps from –100 to 0 mV (Figure S1A). We observed run-
up in current amplitude over 5 min to a stable level (Figure S1B)
with the current completely inhibited by CdCl2 (100 mM;
Figure S1A). CaV are classified as L, T, P, Q, N, and R types
based on molecular, biophysical, and pharmacological proper-
ties (Catterall et al., 2005). Thus, a pharmacological dissection
of POMC CaV was performed using Ba
2+ currents at 0 mV. Addi-
tion of mibefradil (10 mM), an R- and T-type (and partial L-type)
inhibitor, followed by the N-type blocker u-conotoxin-GVIA
(200 nM) and L-type blocker nimodipine (10 mM), each inhibited
evoked currents by similar magnitudes (Figures S1C and S1E). In
the presence of all three CaV blockers, application of the P- and
Q-type blocker u-agatoxin-IVA (200 nM) reduced current ampli-
tude further (Figures S1D and S1E). This cocktail of blockers did
not completely suppress POMC CaV currents, indicating the
presence of a resistant (‘‘R-type’’) conductance. However,
50 nMSNX-484 (which blocks R currents inmost but not all cells;
Newcomb et al., 1998) did not affect the Ba2+ current amplitude
(Figure S1F).
Next, we tested whether leptin modulates a specific CaV cur-
rent. Following establishment of a stable current amplitude, lep-
tin increased the Ba2+ current at 0 mV (D current,27.5 ± 9.8 pA;
n = 10; paired t test, t(9) = 2.81; p < 0.03) and by a greater magni-
tude at 30 mV (D current, –79.7 ± 30.4 pA; n = 10; paired t test,
t(9) = 2.63; p < 0.03), which was sustained following leptin
removal (Figures 1C–1F). Augmentation of the Ba2+ current
was unaffected by 10 mM nimodipine (D current at 0 mV,(B) Representative currents evoked by hyperpolarizing voltage ramps (10 to 
indicated (left). Currents evoked by leptin (subtraction of control from leptin current
inward current (boxed region) shown expanded (right).
(C) Barium currents evoked from POMC neurons in intact slices by voltage steps to
ensemble barium currents are shown immediately before (black) and following (r
(D) Diary plots of barium current amplitude evoked at 0 mV plotted against time i
(F(12,101) = 2.51; p = 0.006) with deviation from baseline control examined by o
(E) Barium currents evoked in intact slices by voltage steps to 30 mV from a hol
following (red) locally applied leptin (50 nM), where indicated.
(F) Diary plots of barium current amplitude evoked at 30 mV plotted against tim
ANOVA: absence (F(12–119) = 2.91; p = 0.0016) with deviation from baseline co
(G) Barium currents were evoked from dispersed POMC neurons by voltage ste
presence of leptin (red).
(H) Diary plot for the recording shown in (J) and following addition and removal o
280 Cell Reports 25, 278–287, October 9, 2018–26.6 ± 8.6 pA; n = 10; paired t test, t(9) = 3.08; p < 0.02).
However, leptin-induced augmentation was prevented by
10 mM mibefradil (D current at 30 mV, –8.0 ± 8.9 pA; n = 9;
paired t test, t(8) = 0.90; p = 0.39) and a PI3K inhibitor TGX-
221 (1 mM; D current, –13.2 ± 23.4 pA; n = 13; paired t test,
t(12) = 0.57; p = 0.58). We next examined leptin action on Ba2+
currents in acutely dissociated POMC neurons to exclude the
possibility that changes in network activity were responsible
for the augmentation of the CaV conductance. However, the
Ba2+ current evoked at 40 mV was increased by leptin in
dispersed POMC neurons by 24.9 ± 0.9% (n = 7; paired t test,
t(6) = 2.65; p < 0.04; Figure 1G) and blocked by NiCl2 (100 mM;
n = 3; Figure 1H), which inhibits T- and R-type conductances.
Although the mibefradil-sensitive Ba2+ current has slow inactiva-
tion kinetics, we assessed leptin action on T-type calcium chan-
nels (also Ni2+ and mibefradil sensitive). Ba2+ currents, elicited at
–50 mV in dispersed POMC neurons, displayed the rapid and
transient current profile of T-type channels (tinact, 3.1 ± 0.9 ms;
n = 4; Figure S1G). Leptin did not alter the amplitude (Imax: con-
trol, 148.1 ± 62.7 pA, versus leptin, 166.6 ± 50.7 pA; n = 4; paired
t test, t(3) = 0.68; p = 0.55) or steady-state inactivation (V0.5: con-
trol,91.8 ± 2.5mV, versus leptin,91.4 ± 24.7mV; n = 4; paired
t test, t(3) = 0.12; p = 0.91; Figures S1G and S1H) of these
currents.
Cell-Specific Knockdown of Cacna1e in POMC Neurons
These characteristics of the leptin-modulated CaV conductance
are consistent with R type, where the pore-forming subunit is
CaV2.3 (Cacna1e). To investigate its role in POMC neurons, we
used interference short hairpin RNA (shRNA) sequences
directed towardCacna1e (Figure 2A). Hypothalamic GT1-7 cells,
which express R-type CaV, were independently transfected with
each shRNA sequence directed toward Cacna1e or GFP as a
control and Ba2+ currents evoked at 0 mV. For each shRNA
sequence, peak Ba2+ currents were reduced by 75%–85%
when compared to GFP-transfected cells (Figure 2B). To target
POMC cells in vivo, we used the approach of Hitz et al. (2007),
whereby a loxP flanked stop cassette was introduced between
the U6 promoter and the 50 end of the shRNA sequence. To iden-
tify expression, mCherry driven by the CMV promoter was in-
serted downstream of the shRNA (#2) sequence in an associ-
ated-adenovirus (AAV) expression vector (Figure 2C). To test
the efficacy of this strategy, brains of wild-type (WT) (/) and
nestin-cre-recombinase (/+)-expressing mice were injected100 mV; 2-s duration) in the presence and absence of leptin (50 nM), where
s) is shown for thewhole current-voltage relationship (middle) with the switch to
0mV from a holding potential of100mV. Mean (five consecutive test pulses)
ed) locally applied leptin (50 nM), where indicated.
n the absence and presence of leptin (mean ± SEM; n = 10). One-way ANOVA
ne-sample t test. *p < 0.05.
ding potential of 100 mV. Mean ensemble barium currents before (black) and
e before and after leptin (50 nM) application (mean ± SEM, n = 10). One-way
ntrol examined by one-sample t test. *p < 0.05.
ps to 40 mV from a holding potential of 70 mV in the absence (black) and
f bath applied NiCl2 (100 mM, where indicted).
Figure 2. shRNA Knockdown of Cacna1e in POMC Neurons
(A) shRNA sequences targeting the mouse Cacna1e gene.
(B) Barium currents were evoked in GT1-7 cells by voltage steps to 0 mV from a holding potential of100 mV. Cells were transfected with GFP or one of the four
shRNA sequences (#1–4) shown in (A). Mean ± SEM; n = 9. One-way ANOVA (F(4,40) = 11.21, p < 0.0001); Bonferroni post hoc, ****p < 0.0001.
(C) Diagrammatic representation of the associated-adenoviral (AAV) expression vector before (top) and after cre recombination (bottom).
(D) Western blot analysis of CaV2.3 (Cacna1e) protein (top), Na
+/K+ ATPase loading control (bottom), and quantification (right bar chart; mean ± SEM) for brain
lysates from wild-type (/) and nestinCre (/+) mice injected with AAV particles containing the shRNA #2 sequence shown in (A).
(legend continued on next page)
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with viral particles containing the shRNA sequence directed
to Cacna1e. CaV2.3 (Cacna1e) protein was reduced in AAV-
injected brains in cre-positive mice compared to WT litter-
mates (Figure 2D), demonstrating effective knockdown of
Cacna1e. Viral particles were then injected into the MBH
of WT and POMCCre mice to generate POMCCacna1eWT
and POMCCacna1eKD mice, respectively. To control for
potential off-target effects, we also injected a cre-dependent
shRNA scramble virus into POMCCre mice to produce
POMCshRNAscramble mice. Immunohistochemistry for POMC
and mCherry confirmed expression in POMC neurons and the
MBH (Figure 2E). Expression of mCherry was examined post
mortem in all mice to confirm correct viral placement. For
in vitro brain slice studies, as mCherry expression was cre
independent, we crossed POMCCre with POMCGFP mice to
visualize POMC neurons. Current-voltage relationships of Ba2+
currents were recorded frommCherry and GFP-positive arcuate
neurons in POMCCacna1eWT and POMCCacna1eKD mice.
Consistent with knockdown of R-type CaV in Cre-positive
POMC neurons, peak current density was reduced with a shift
in the current-voltage relationship to depolarizing potentials
(Figure 2F). It is likely that the remaining barium currents are a
mix of the other classes of CaV conductance present in POMC
neurons (Figures S1C–S1H).
Resting Vm, firing frequency, and input resistance were unal-
tered between WT and Cacna1e knockdown POMC neurons
(Figure 3A). During the initial 2-min application period, leptin
(50 nM) equally depolarized POMCCacna1eWT (n = 12; paired
t test, t(12) = 3.98; p < 0.003), POMCCacna1eKD (n = 15; paired
t test, t(14) = 3.69; p < 0.003), and POMCshRNAscramble (n = 9;
paired t test, t(8) = 2.59; p < 0.04) neurons (Figures 3B–3D). How-
ever, 10min after leptin application, depolarization was only sus-
tained in the POMCCacna1eWT and POMCshRNAscramble
neurons (Figure 3D), suggesting that CaV2.3 subunit is required
for the long-term depolarizing activity of leptin.
Knockdown of Cacna1e Does Not Abolish Leptin
Suppression of Feeding
Prenatal leptin receptor deletion inPOMCneurons increasesbody
weight, fat mass, and serum leptin. However, knockdown of
POMC neuron Cacna1e in adult mice did not alter body weight
or fastedserum leptin compared toPOMCCacna1eWT littermates
(Figures 4A and 4B). Ad libitum or fast-refed food intakewere also
unaffected (Figures4Cand4D), andexogenous leptin suppressed
feeding and reduced body weight equally in POMCCacna1eWT
and POMCCacna1eKD mice (Figures 4E and 4F).
Knockdown of Cacna1e in POMC Neurons Leads to
Increased HGP and Insulin Resistance
Leptin action in the MBH regulates peripheral glucose homeosta-
sis including HGP and insulin sensitivity, and deletion of signaling
molecules in POMC neurons impairs peripheral glucose disposal(E) POMCCre mice injected with the shRNA construct in the MBH. Cre-independ
shown to co-localize (right).
(F) Mean current-voltage plot (left) and representative traces (right) for Ba2+ curren
by rainbow colors, right) in POMCCacna1eWT and POMCCacna1eKD mice (mea
F(1,39) = 2.82, p = 0.0032); Bonferroni post hoc, *p < 0.05, **p < 0.01, ***p < 0.00
282 Cell Reports 25, 278–287, October 9, 2018and insulin sensitivity (Ruud et al., 2017). Thus, we measured
fasted serum insulin and glucose levels in POMCCacna1eWT,
POMCCacna1eKD, and POMCshRNAscramble littermate mice
8 weeks after viral injection. Serum insulin was increased in
POMCCacna1eKD mice compared to POMCCacna1eWT litter-
mates (Figure 4G) with glucose levels unaltered (Figure 4H).
Similarly, serum insulin levels were increased (unpaired t test,
t(8) = 3.14; p < 0.04) in POMCCacna1eKD (0.74 ± 0.03 ng/mL;
n = 6) mice when compared to POMCshRNAscramble
(0.48 ± 0.10 ng/mL; n = 4) littermate controls. This suggested
the presence of insulin resistance, and so we undertook
hyperinsulinemic-euglycemic clamp studies. Under basal and
hyperinsulinemic conditions, glucose disposal (Rd) rate was
unchanged (Figure 4I). However, HGPwas significantly increased
with a trend (unpaired t test, t(14) = 1.90; p = 0.078) to
lower glucose infusion rates (GIRs) in POMCCacna1eKD
mice (Figure 4I). 2-Deoxyglucose-phosphate (2DG-P) uptake
into muscle, brown adipose tissue (BAT), and white adipose
tissue (WAT) was unaltered between POMCCacna1eWT and
POMCCacna1eKD mice (Figure 4J). Insulin-induced suppression
of serum free-fatty acid (FFA) production was also unaffected by
Cacna1e knockdown in POMC neurons (Figure 4K).
To investigate potential mechanism(s) for insulin resistance, we
performed qPCR in hypothalamic and liver tissue from fasted
mice. We observed no differences in hypothalamic expression
of Pomc, glucokinase (Gck), or glucose transporter-2 (Slc2a2) in
POMCCacna1eWT and POMCCacna1eKD mice (Figure 4L).
However, liverGckexpressionwas reduced inPOMCCacna1eKD
mice, while interleukin-6 (Il6), phosphoenolpyruvate carboxyki-
nase (Pck1), and glucose-6-phosphatase (G6pc) were unaltered
(Figure 4M).
DISCUSSION
Our studies identify in POMC neurons a leptin-sensitive CaV cur-
rent with R-type characteristics containing the pore-forming
subunitCacna1e. This plays a key role inmediating the sustained
effects of leptin on POMC neuron excitability and the subse-
quent regulation of glucose homeostasis.
Leptin excites POMC neurons by activation of a non-selective
conductance composed of Trpc subunits (Qiu et al., 2010). This
activation was dependent on internal calcium, as found for Trpc5
subunits in heterologous expression systems (Blair et al., 2009).
Consistent with Trpc activation, we also observed that leptin
caused a reduction in input resistance at resting potentials and
increased inward current at steady-state potentials. In hyperpo-
larizing voltage ramps, leptin induced a current that reversed
close to the predicted reversal potential for a non-selective
cation channel. Recently, Gao et al. (2017) deleted Trpc5
from POMC neurons, causing a loss of leptin-induced
depolarization and reduced basal excitability. Many non-selec-
tive conductances, including Trpc5, are modulated by raisedent mCherry expression (left) and POMC immunohistochemistry (middle) are
ts evoked in POMC neurons at voltages between60 and +20mV (as denoted
n ± SEM; n = 14–27). Two-way repeated-measures (RM) ANOVA (interaction:
1.
Figure 3. Knockdown of Cacna1e Prevents Chronic Leptin-Induced Depolarization
(A) Bar charts showing resting membrane potential (Vm, left), spike firing frequency (middle), and input resistance (right) in POMC neurons from
POMCCacna1eWT (red; n = 12), POMCCacna1eKD (blue; n = 15), and POMCshRNAscramble (black; n = 9) mice. Mean ± SEM; one-way ANOVA
(Vm: F(2,33) = 0.17, p = 0.85; spike: F(2,33) = 0.61, p = 0.55; input: F(2,33) = 0.06, p = 0.94).
(legend continued on next page)
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intracellular calcium, and since we also observed a leptin-acti-
vated voltage-dependent conductance, we postulated that this
could facilitate leptin-induced POMC excitation. As Cacna1e
channels are likely to be inactive at resting potentials (approxi-
mately –50 mV), activation of Trpc5 and/or increased firing and
excitatory synaptic input may be required to activate Cacna1e
channels, allowing calcium entry to augment Trpc5 channel
opening. Such a positive feedforward mechanism could explain
the sustained depolarization induced by brief exposure to leptin.
Indeed, Cacna1e knockdown prevented chronic but not acute
leptin-induced depolarization, suggesting that Trpc5 activation
without calcium entry is insufficient to depolarize POMC neurons
over longer periods. Given leptin’s dependence on uptake
mechanisms to enter the brain (Banks and Farrell, 2003), it is
not surprising that circulating leptin slowly activates POMC neu-
rons in vivo (Beutler et al., 2017). Thus, it is far more probable that
the loss of Cacna1e would impact on the overall magnitude of
leptin response in vivo rather than altering the temporal pattern
of activation.
Prenatal deletion of LepR in POMC neurons does not affect
food intake or energy expenditure but causes obesity and re-
duces Pomc expression (Balthasar et al., 2004). Overexpression
of LepR in all POMC neurons in mice globally null for the LepR
diminishes hyperphagia, whereas re-introduction of LepR into
POMC neurons originally containing LepR minimally affects
food intake (Berglund et al., 2012; Huo et al., 2009). Neverthe-
less, both models displayed improved glucose and insulin sensi-
tivity. POMC neurons are important for hepatic parasympathetic
nerve activity in response to leptin (Bell et al., 2018), but it is un-
clear whether POMC neurons regulate HGP directly through the
autonomic nervous system, or indirectly by altering metabolic
hormones. Recently, POMC neuron-specific deletion of the
LepR in adult mice has been shown to impair insulin-induced
suppression of HGP independent of changes in energy balance
(Caron et al., 2018). These findings therefore show dissociation
between the effects of leptin on glucose homeostasis and
feeding and body weight regulation. Overexpression of suppres-
sor of cytokine signaling-3 (Socs3) in POMC neurons increases
adiposity and blocks leptin reduction in food intake (Reed
et al., 2010) and POMC deletion of Socs3 reduces body weight,
enhances leptin suppression of food intake, and improves pe-
ripheral glucose homeostasis (Kievit et al., 2006). Deletion of
the LepR signaling molecule, signal transducer and activator of
transcription-3 (Stat3), in POMC neurons causes mild obesity
in female mice and reduces Pomc gene expression (Xu et al.,
2007). Consistent with the idea of divergent outputs for leptin
signaling in POMC neurons and with the differences between
prenatal and adult-specific suppression of leptin signaling,
knockdown of Cacna1e only in arcuate POMC neurons did not
alter food intake, leptin suppression of feeding, or body weight
but caused defective regulation of HGP and insulin resistance
in adult mice. The elevated fasted serum insulin may have(B and C) Representative continuous whole-cell current-clamp traces (upper) a
POMCCacna1eWT (B) and POMCCacna1eKD (C) mice. Leptin was locally applie
(D) Bar charts showing leptin-induced depolarization (inclusive of non-respon
neurons from POMCCacna1eWT (red; n = 12), POMCCacna1eKD (blue; n = 15), a
(F(5,66) = 2.36; p = 0.05); Bonferroni post hoc *p < 0.05.
284 Cell Reports 25, 278–287, October 9, 2018occurred due to hepatic insulin resistance in order to maintain
normal glucose levels. In contrast, deletion of Trpc5 in all
POMC neurons leads to an age-dependent increase in body
weight, with increased food intake, decreased energy expendi-
ture, and attenuated leptin-mediated anorexia, although glucose
homeostasis was unchanged (Gao et al., 2017). Our data
indicate a subtle change in insulin sensitivity detected using
highly sensitive hyperinsulinemic-euglycemic clamps. It is also
possible that reduced resting excitability by Trpc5 deletion in
POMC neurons increases body weight and feeding independent
of leptin. Indeed, POMC Trpc5 expression is required, in part, for
effective serotoninergic action on feeding. Moreover, the mildly
obese phenotype in Trpc5-deleted mice may contribute to leptin
resistance attenuating leptin-induced anorexia and excitability.
In summary, the R-type (CaV2.3 or Cacna1e) channel is
required for long-term leptin depolarization and excitation of
POMC neurons in vitro. Furthermore, our findings suggest
Cacna1e is an important component of the ion channel assem-
blage in arcuate POMC neurons required for the maintenance
of normal glucose homeostasis.
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n = 11–14). Unpaired t test (t(23) = 1.62; p = 0.119).
(C) Ad libitum daily food intake in 5-month-old male
POMCCacna1eWT (red) and POMCCacna1eKD
(blue) mice (mean ± SEM; n = 14–16). Unpaired
t test (t(28) = 0.506; p = 0.617).
(D) Cumulative 24-hr food intake following
an overnight fast in 5-month-old male
POMCCacna1eWT (red) and POMCCacna1eKD
(blue) mice (mean ± SEM; n = 14–16). Two-way RM
ANOVA (F(1,28) = 0.0024; p = 0.962).
(E) Change in food intake following leptin
administration (1.5 mg/kg twice daily for 3 days)
expressed as percentage of vehicle in 6-month-old
POMCCacna1eWT (red) and POMCCacna1eKD
(blue) mice (mean ± SEM; n = 13–16). Unpaired
t test (t(27) = 1.20; p = 0.240).
(F) Change in body weight following leptin admin-
istration in the mice shown in (E). Unpaired t test
(t(27) = 0.964; p = 0.344). Mean ± SEM.
(G) Fasted serum insulin concentration in
7-month-old male POMCCacna1eWT (red) and
POMCCacna1eKD (blue) mice (mean ± SEM;
n = 21–22). Unpaired t test (t(41) = 3.51; p = 0.0011).
**p < 0.01
(H) Fasted blood glucose concentration in
7-month-old male POMCCacna1eWT (red) and
POMCCacna1eKD (blue) mice (mean ± SEM;
n = 11–17). Unpaired t test (t(26) = 1.73; p = 0.0957).
(I) Glucose disposal (Rd), glucose infusion rate (GIR),
and HGP during basal and hyperinsulinemic-eugly-
cemic clamp conditions from POMCCacna1eWT
(red) and POMCCacna1eKD (blue) mice
(mean ± SEM; n = 8). Unpaired t test: basal Rd
(t(14) = 1.23; p = 0.240); clamp Rd (t(14) = 0.396;
p = 0.698); GIR (t(14) = 1.90; p = 0.079); HGP
(t(14) = 2.37; p = 0.0325). *p < 0.05.
(J) Skeletal muscle, BAT, epidermalWAT (eWAT), and
subcutaneous WAT (scWAT) uptake of 14C-2-deoxy-
glucose-phosphate (2-DG-P) in hyperinsulinemic-
euglycemic clamped POMCCacna1eWT (red) and POMCCacna1eKD (blue) mice described in (C). Mean ± SEM. Unpaired t test: muscle (t(14) = 1.71, p = 0.110); BAT
(t(12) = 0.942, p = 0.365); eWAT (t(14) = 0.917; p = 0.375); scWAT (t(10) = 0.825; p = 0.428).
(K) Serum free-fatty acid (FFA) concentration during basal and hyperinsulinemic-euglycemic clamp conditions from POMCCacna1eWT (red) and
POMCCacna1eKD (blue) mice described in (C). Mean ± SEM. Unpaired t test: basal (t(14) = 0.795; p = 0.440); clamp (t(14) = 0.990; p = 0.339).
(L) qPCR for Gck, Slc2a2, Pomc in hypothalamic tissue from fasted POMCCacna1eWT (red) and POMCCacna1eKD (blue) mice (mean ± SEM; n = 13–17).
Unpaired t test: Gck (t(27) = 0.148, p = 0.883); Slc2a2 (t(27) = 1.15; p = 0.259); Pomc (t(27) = 0.417; p = 0.680).
(M) Expression of G6pc, Gck, Pck1, and IL6 in liver tissue from fasted POMCCacna1eWT (red) and POMCCacna1eKD (blue) mice (mean ± SEM; n = 12–16).
Unpaired t test: G6pc (t(27) = 0.486, p = 0.631); Gck (t(25) = 2.15; p = 0.0418); Pck1 (t(27) = 0.795; p = 0.433); IL6 (t(27) = 0.578; p = 0.568). *p < 0.05.(068692). Euglycemic-hyperinsulinemic clamps were conducted by the Dis-
ease Model Core, MRC Metabolic Diseases Unit (MRC_MC_UU_12012/5).
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EXPERIMENTAL MODEL AND SUBJECT DETAILS
In-vivo animal studies
POMCCre (Xu et al., 2005), NestinCre (B6.Cg-Tg(Nes-cre)1Kln/J), Z/EG (Tg(CAG-Bgeo/GFP21Lbe/J) and POMCGFP (B6.Cg-
Tg(Pomc-MAPT/Topaz)1RCK/J) (Pinto et al., 2004) mice were bred on a C57BL/6J background and maintained on a 12 h light/
dark cycle with free access to water and standard mouse chow (4.25% fat, RM3, Special Diet Services). Mice were housed in
specific-pathogen free barrier facilities in individually ventilated cages of mixed genotypes. Male transgenic mice were age-matched
(4-8months) and studied with littermate controls. Mice were handled and all studies performed in accordance to the United Kingdom
Animals (Scientific Procedures) Act (1986), amended regulations (2012), and approved by Imperial College and University of
Cambridge Animal Welfare and Ethical Review Bodies. Findings and experiments described in this paper were designed and
reported following the Animal Research: Reporting of In Vivo Experiments (ARRIVE) guidelines of animal experiment reporting
(Kilkenny et al., 2010). Where possible, investigators were blinded to the genotype of both study animals and that of tissue and blood
samples. For experiments involving treatments, micewere randomized by genotype to study groups or a cross-over designwas used
where indicated and study cohorts were matched for initial bodyweight where appropriate. Treatments were administered in random
order. Mice were group housed (3-5 per cage) unless stated.
Stereotactic surgery
Male (4-6 month) POMCCre and NestinCre mice were anesthetized with isoflurane and placed in a KOPF stereotaxic frame.
Analgesia was administered by topical bupivacaine (8mg/kg) and subcutaneous injection (5mg/kg) of carprofen during surgery,
followed by the addition of carprofen to the drinking water (0.0272mg/ml) for 3-5 days post-surgery. Adeno-associated viral particles
(AAV1 capsid) containing the cre-dependent shRNA construct (0.6-2.8 3 1013 GC/ml) or shRNA scramble (2.0 3 1013 GC/ml) were
injected bilaterally with a Hamilton syringe (0.3 ml/min, 0.3 mL per inject site) into the arcuate nucleus at1.2 mmposterior to bregma,
± 0.4mm lateral to themidline and6.1,5.8mmventral to the surface of the skull. Co-ordinates for cortical injections into NestinCre
mice were +0.5 mm posterior and ± 1.8 mm lateral from bregma and 2.0, 1.5 mm ventral from the surface of the skull. Mice were
group housed and left for a minimum of 4-weeks post-surgery to recover before metabolic measurements or electrophysiological
studies were performed. Viral expression of mCherry was used to confirm correct stereotaxic placement post-mortem.
Cell Culture
Hypothalamic GT1-7 cells (Mellon et al., 1990) weremaintained in a high glucose Dulbecco’sModified EagleMedium (DMEM, Sigma)
supplemented with fetal bovine serum (10% v/v), L-glutamine (8 mM), penicillin/streptomycin (2% v/v) and plated on poly-L-lysine
coated flasks or glass coverslips. Cell were transfected 2 days following passage (1:6-1:8 density) with FuGENE (Promega) at a ratio
of 2:1 reagent to cDNA. Cells were transfected with cDNA containing Egfp in the pcDNA3.1mammalian expression vector, or with the
shRNA sequences in the pLK0.1 lentiviral expression vector. Cells expressing the puromycin selection marker in the pLK0.1 vector
were treated with puromycin (5 mg/ml) for 2-3 days. All electrophysiological recordings were performed on GT1-7 cells 4-5 days post
passage.
METHOD DETAILS
Metabolic and food intake studies
Studies were performed in the animal’s home cage unless indicated. Bodyweights from group-housed mice were measured weekly
at 9-10am up to 5-6 weeks post-surgery. Fasted tail blood was analyzed for serum leptin (Millipore) and insulin (Crystal Chem) by
ELISA 8 weeks post-surgery. For food intake studies, mice were group housed until 4 weeks post-surgery and then singly housed.
Mice were allowed to acclimatize for 2 weeks and periodically fasted overnight. Ad-libitum food intake wasmeasured over 3 consec-
utive days and for 24 h following an overnight fast. Food intake was measured from singly housed mice injected with either vehicle or
leptin (i.p. 1.5 mg/kg) at 9am and again at 6pm for 3 consecutive days. Treatments with either vehicle or leptin were crossed-over
following a week wash-out period.
Hyperinsulinemic-euglycemic clamps studies
Clamps were conducted as previously described (Voshol et al., 2001). Animals were anesthetized by intraperitoneal injection of a
combination of 6.25 mg/kg acetylpromazine, 6.25 mg/kg midazolam and 0.31 mg/kg fentanyl. An infusion needle was placed into
the tail vein and D-[3H] glucose (specific activity: 10-20Ci (370-740GBq)/mmol) was infused at a rate of 0.006 MBq/min for 80 min
to achieve steady-state levels. Thereafter, insulin (Actrapid; NovoNordisk) was infused at a constant rate of 0.11mU/min after a bolus
dose of 3.3 mU and D-[3H]-glucose was continued at a rate of 0.006 MBq/min. A variable infusion of 12.5% D-glucose was used to
maintain blood glucose at euglycemic (basal) levels. Blood glucose was measured with an AlphaTRAK glucometer (Abbott
Animal Health) every 5-10 minutes and glucose infusion adjusted accordingly. After 60 minutes from the start of the insulin infusion,
14C-2-Deoxy-glucose-phosphate (Specific Activity: 250-350mCi (9.25- 13.0GBq)/mmol) was administered i.v. to assess tissue-spe-
cific glucose uptake. Steady-state was reached after 60 minutes and blood samples were taken at 10 minutes intervals over
30 minutes to determine steady-state levels of [3H]-glucose. Mice were then killed by cervical dislocation and the organs removedCell Reports 25, 278–287.e1–e4, October 9, 2018 e2
and frozen. To measure plasma [3H]-glucose, proteins were precipitated with trichloroacetic acid (final concentration 10%), centri-
fuged, and supernatant dried and re-suspended in water. The samples were counted using scintillation counting (Hidex Scintilation
counter, LabLogic). Muscle and brown adipose tissue samples were homogenized (5%–10% wet wt/vol, depending on tissue) in
0.5% percholic acid, centrifuged, supernatants neutralized, and 14C-2-Deoxy-glucose-phosphate precipitated using BaOH/ZnSO4.
Total and precipitated counts of supernatants were subtracted and plasma 14C-2-Deoxy-glucosephosphate counts were used to
calculate tissue specific uptake. Protein content in homogenates was performed using DC protein assay (BioRad). For subcutaneous
and epidermal white adipose tissue, 14C-2-Deoxy-glucose-phosphate was extracted using anion exchange columns as
described previously (Kim, 2009). The glucose turnover rate (mmol/min) was calculated during the basal period and under steady-
state clamp conditions as the rate of tracer infusion (dpm/min) divided by the plasma specific activity of [3H] glucose (dpm/mmol).
Hyperinsulinemic hepatic glucose production was calculated as the difference between the tracer-derived rate of glucose appear-
ance and the glucose infusion rate.
Plasmids
Egfp was sub-cloned into the pcDNA3.1 expression vector. Four separate shRNA clones directed toward Cacna1e (#1:
TRCN0000068910, #2: TRCN0000068912, #3 TRCN0000068908, #4: TRCN0000068911) were purchased from Thermo-Scientific
(RMM4534) in the pLK0.1 lentiviral expression vector. A cDNA sequence comprising the U6 promoter, followed by a LoxP flanked
stop cassette (Hitz et al., 2007) and the shRNA sequence (#2: TRCN0000068912) was synthesized by GeneArt (Life Technologies).
Unique restriction sites Spe1 and Swa1 were inserted at the ‘3 end of the synthesized cDNA. The cDNA was subcloned into a pAAV
expression vector (pAAV-EFa-DIO-hChR2-mCherry-WPRE) between Mlu1 and EcoR1 removing the EFa-DIO-hChR2-mCherry
sequence from the plasmid at the same time. A sequence containing theCMVpromoter andmCherry was then synthesized (GeneArt)
and inserted into the pAAV vector using the Spe1 and Swa1 sites to make the final construct (pAAV-U6-[LoxP-STOP-LoxP]-shRNA
[Cacna1e]-CMV-mCherry-WPRE). Scramble shRNA (GAGAATACCGACAAAGATACT, designed using Invivogen’s siRNA Wizard
software) was synthesized by GeneArt (Life Technologies) and inserted into a pAM-FLEX-GFP vector (Murray et al., 2011).
Genotyping
Generic Cre-recombinase (forward: 50-AGCGATGGATTTCCGTCTCT and reverse: 50-CACCAGCTTGCATGATCTCC) and GFP
(forward: 50-AGCTAGCCACCATGGTGAGCAAGG GCGAGGAG and reverse: 50-ATCTCGAGCTTGTACAGCTCGTCCATGCCG)
primers were used to genotype POMCCre, NestinCre and POMCGFP mice. Positive cre-recombinase bands were observed at
approximately 200 bp and for GFP at 600 bp.
Quantitative RT-PCR analysis
Tissues were lysed and homogenized in TRIzol reagent (Ambion) and total RNA was isolated using the RNeasy mini kit (QIAGEN).
First-strand cDNA was generated using Taqman reverse transcription reagents (Applied Biosystems) and qPCR was performed us-
ing Taqman universal PCRmastermix in a 7900HT real-time PCR system (Applied Biosystems). mRNA quantities were normalized to
Hprt after determination by the comparative Ct method. Primers used were:Gck (Mm00439129_m1),G6Pc (Mm00839363_m1) Hprt
(Mm00446968_m1), Pck1 (Mm01247058_m1), Pomc (Mm00435874_m1), Slc2a2 (Mm0044622_m1), IL6 (Mm00446190_m1).
Western blot analysis
Cortices were removed and homogenized in lysis buffer (50 mM Tris pH 7.4, 150 mM NaCl, 1 mM EDTA, 1% w/v Triton X-100) sup-
plemented with Roche complete protease inhibitor cocktail and phosphatase inhibitors (1 mM sodium orthovadanate, 5 mM sodium
fluoride and 2 mM b-glycerophosphate). 20-100 mg of total protein homogenates were run on 15% SDS-PAGE gels, transferred to
nitrocellulose membranes and blotted with antibodies against CaV2.3 (1:1000, #ACC-006 Alomone Labs) and Na
+/K+-ATPase a-1
(1:1000, #05-369 Millipore). Detection was performed using enhanced chemiluminescence (Luminata Crescento, Millipore) and
exposed on films. The intensity of the bands was quantified by densitometry using Adobe Photoshop software and normalized to
Na+/K+-ATPase protein.
Hypothalamic immunohistochemistry
Mice were perfused with paraformaldehyde (4% w/v) and frozen coronal sections (35 mm) were cut for immunohistochemistry as
previously described (Choudhury et al., 2005). Arcuate sections were incubated with rabbit anti-POMC precursor (1:1000; Phoenix
Pharmaceuticals Inc.) and detection performed using a secondary antibody coupled to Alexa Fluor-488 (1:200, Molecular Probes).
Electrophysiology
Mice were killed by cervical dislocation and hypothalamic coronal slices (350 mm) were cut from agedmatched (5-6 month old) trans-
genic mice expressing POMCCre and POMC-GFP or POMCCre and Z/EG. Slices were maintained at room temperature (22-25C) in
an external solution containing (in mM) NaCl 125, KCl 2.5, NaH2PO4 1.25, NaHCO3 25, CaCl2 2, MgCl2 1, D-glucose 10, D-mannitol
15, equilibrated with 95% O2, 5% CO2, pH 7.4. For intact slice studies, POMC neurons were visualized in the arcuate nucleus by
video-enhanced differential interference contrast microscopy and by the expression and excitation of GFP. In addition, arcuate
wedges from slices containing GFP labeled POMC neurons were dissected and incubated for 1 h in the standard external solutione3 Cell Reports 25, 278–287.e1–e4, October 9, 2018
containing 0.5 mg/ml protease (type XIV) at room temperature. Following several washes with a HEPES (10 mM, pH 7.4) based
external solution, individual neurons were dispersed by gentle trituration with fire polished glass Pasteur pipettes with decreasing
tip aperture, as previously described (Spanswick et al., 1997). The cell suspension was evenly plated on concanavalin A (1 mg/ml)
coated 35 mm culture dishes (Falcon) and left for 1 hour at 4C allowing cell adhesion prior to use. Cells were visualized by phase
contrast microscopy and POMC neurons identified by GFP expression and excitation.
Whole-cell current-clamp recordings were made at 33C using borosilicate glass pipettes (4-8 MU) containing (in mM) Kgluconate
130, KCl 10, EGTA 0.5, NaCl 1, CaCl2 0.28, MgCl2 3, Na2ATP 3, GTP 0.3, phosphocreatine 14 and HEPES 10 (pH 7.2). Following the
establishment of a stable recording, leptin (R&D Systems) was applied for 2minutes using a broken tipped pipette (3 mm) positioned
above the recording neuron. For qualitative descriptions only, responsive neurons were distinguished from non-responding neurons
based on the criterion that the change in membrane potential by leptin challenge was ± three times the standard deviation prior to
addition of the drug. In voltage-clamp studies, neurons were recorded in the standard external solution in the presence of 1 mM
tetrodotoxin, 20 mM (+)-bicuculline and 2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo(f)quinoxaline-2,3-dione (NBQX, 5 mM) with D-2-
amino-5-phosphonopentanoate (D-AP5, 50 mM). Neurons that changed series resistance (10-30 MU) were excluded from the anal-
ysis. Neurons were held at 70 mV and voltage-ramped (10 to 100 mV over 2 s) every minute. In order to identify the conduc-
tances activated by leptin, the mean of 5 voltage ramps before leptin application was subtracted from mean of 5 ramps following
leptin application. Voltage-gated calcium (CaV) currents were recorded with a standard internal solution but with K
+-gluconate re-
placed by 130 mM CsCl. The CaV conductance was further isolated by an external solution containing in mM: NaCl 125, KCl 2.5,
BaCl2 10, D-glucose 10, D-mannitol 15 and HEPES 10, pH 7.4. Series resistance and whole-cell capacitance were compensated
(40%–70%) using an Axopatch 200B amplifier. Any uncompensated resistance and capacitance were digitally (IgorPro7) subtracted
using an equivalent voltage-step protocol in which CaV was inactivated by voltage-clamping the neuron at 0 mV forR 2 minutes.
Leptin was applied for 2 minutes following the establishment of a stable recording. An average of 5 consecutive trials before and
immediately after leptin application was used to assess mean change in current.
Stock chemicals were dissolved and added to the appropriate external or internal solution prior to recording. Tetrodotoxin, SNX-
482 and D-AP5were from Tocris (UK);u-conotoxin GVIA andu-agatoxin IVAwere purchased from Alomone Labs (Israel); mibefradil,
(+)-bicuculline, NBQX and nimodipine were from Sigma-Aldrich
QUANTIFICATION AND STATISTICAL ANALYSIS
Statistical significance was calculated from all neurons (responsive and non-responsive) using repeated-measures (RM) two-way
ANOVA and one-way ANOVA followed by Bonferroni post hoc analysis, Student’s two-tailed paired and unpaired t test, or one-sam-
ple t test where stated. Data are expressed as mean ± standard error of mean and degrees of freedom shown in brackets. A
maximum of 2 recordings were made from any given mouse. Recordings and observations were repeated on at least 4 different
mice. Study cohort sizes were determined by power calculations based on our previous data in mice with targeted hypothalamic
mutations.Cell Reports 25, 278–287.e1–e4, October 9, 2018 e4
